Literature DB >> 19335499

Pressure ulcer prevention in intensive care patients: guidelines and practice.

Eman S M Shahin1, Theo Dassen, Ruud J G Halfens.   

Abstract

BACKGROUND: Pressure ulcers are a potential problem in intensive care patients, and their prevention is a major issue in nursing care. This study aims to assess the allocation of preventive measures for patients at risk for pressure ulcers in intensive care and the evidence of applied pressure ulcer preventive measures in intensive care settings in respect to the European Pressure Ulcer Advisory Panel (EPUAP) and Agency for Health Care Policy and Research (AHCPR) guidelines for pressure ulcer prevention.
DESIGN: The design of this study was a cross-sectional study (point prevalence). Setting The study setting was intensive care units. The sample consisted of 169 patients - 60 patients from surgical wards, 59 from interdisciplinary wards and 50 from medical intensive care wards.
RESULTS: The study results revealed that pressure reducing devices like mattresses (alternating pressure air, low air loss and foam) are applied for 58 (36.5%) patients, and all of these patients are at risk for pressure ulcer development. Most patients receive more than one nursing intervention, especially patients at risk. Nursing interventions applied are skin inspection, massage with moisture cream, nutrition and mobility (81.8%, 80.5%, 68.6% and 56.6%) respectively. Moreover, all applied pressure ulcer preventive measures in this study are in line with the guidelines of the EPUAP and AHCPR except massage which is applied to 8.8% of all patients.
CONCLUSIONS: The use of pressure reducing devices and nursing interventions in intensive care patients are in line with international pressure ulcer guidelines. Only massage, which is also being used, should be avoided according to the recommendation of national and international guidelines.

Entities:  

Mesh:

Year:  2009        PMID: 19335499     DOI: 10.1111/j.1365-2753.2008.01018.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  6 in total

1.  High frequency ultrasound sacral images in the critically ill: Tissue characteristics versus visual evaluation.

Authors:  Mary Jo Grap; Christine M Schubert; Ruth S Burk; Valentina Lucas; Paul A Wetzel; Anathea Pepperl; Cindy L Munro
Journal:  Intensive Crit Care Nurs       Date:  2017-03-06       Impact factor: 3.072

2.  What does quality care mean to nurses in rural hospitals?

Authors:  Marianne Baernholdt; Bonnie Mowinski Jennings; Elizabeth Merwin; Deirdre Thornlow
Journal:  J Adv Nurs       Date:  2010-06       Impact factor: 3.187

3.  Tissue interface pressure and skin integrity in critically ill, mechanically ventilated patients.

Authors:  Mary Jo Grap; Cindy L Munro; Paul A Wetzel; Christine M Schubert; Anathea Pepperl; Ruth S Burk; Valentina Lucas
Journal:  Intensive Crit Care Nurs       Date:  2016-11-08       Impact factor: 3.072

4.  A randomised controlled trial of the effectiveness of soft silicone multi-layered foam dressings in the prevention of sacral and heel pressure ulcers in trauma and critically ill patients: the border trial.

Authors:  Nick Santamaria; Marie Gerdtz; Sarah Sage; Jane McCann; Amy Freeman; Theresa Vassiliou; Stephanie De Vincentis; Ai Wei Ng; Elizabeth Manias; Wei Liu; Jonathan Knott
Journal:  Int Wound J       Date:  2013-05-27       Impact factor: 3.315

5.  Hospital-acquired pressure ulcer incident rates among hospitals that implement an education program for staff, patients, and family caregivers inclusive of an after discharge follow-up program in Saudi Arabia.

Authors:  Alya Al Mutairi; Deborah Schwebius; Abbas Al Mutair
Journal:  Int Wound J       Date:  2020-08-05       Impact factor: 3.315

6.  Selected Biochemical Blood Parameters and a Risk of Pressure Ulcers in Patients Receiving Treatment in Intensive Care Units.

Authors:  Dariusz Bazaliński; Beata Midura; Anna Wójcik; Paweł Więch
Journal:  Medicina (Kaunas)       Date:  2021-02-19       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.